HighTower Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
HighTower Advisors's GSK Position: Q3 2026 in Review
HighTower Advisors increased its GSK (GSK) stake by 0.06% in Q3 2026, buying an estimated $3.88K and bringing the position to 118,336 shares worth $5.7M. The position accounts for 0.01% of the portfolio, ranked #1185.
HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $57.1M in Q1 2022. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- HighTower Advisors held 118,336 shares of GSK worth $5.7M as of Q3 2026.
- HighTower Advisors bought 76 GSK shares in Q3 2026, an estimated $3.88K.
- GSK made up 0.01% of HighTower Advisors's portfolio in Q3 2026, its #1185 holding.
- HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- HighTower Advisors's GSK position peaked at $57.1M in Q1 2022.
- 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.